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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 




















 The effect of HIV co-
infection on C19 in 
SSA is unknown 
 This population cohort 
study found that HIV 
increased risk of C19 
mortality (associated 
with a doubling of C19 
mortality risk), with 
similar risks across 
strata of viral load and 
immunosuppression 
 Current and previous 
TB also increased C19 
mortality risk 
 Authors caution that 
whilst findings may 
over-estimate the HIV-
associated risk C19 
death due to residual 
confounding, it 
remains that those with 
HIV should be 
considered a high-risk 




















 This mixed methods 
review shows that 
fatigue is highly 
prevalent in ICU 
survivors impacting on 
recovery 
 There is currently no 
ICU specific fatigue 
assessment tool or 
targeted intervention to 
manage this symptom 
 This review has 
identified factors which 
may increase or 
mitigate against 
fatigue, along with 
potential management 
strategies for 
consideration in future 








 Careful clinical, 
diagnostic, and 
epidemiological 
studies are needed to 
help define the 
manifestations and 
burden of neurological 
disease caused by 
SARS-coV-2 
 The proportion of 
infections leading to 
neurological disease 
will probably remain 
small, however, with 
so many people 
infected the overall 
number of neurological 
patients, and their 
associated health 
burden and social and 
economic costs might 
be large 
 These patients might 
be left with severe 
neurological sequelae 
 Healthcare planners 
and policy makers 
must prepare for this 
neurology 








 This cross-sectional 
observational study 
aimed to characterise 
the C19 pandemic in 
Brazil and assess 











according to region, 
ethnicity, comorbidities 
and symptoms 
 Finding: increased 
mortality in the north 
region (regional effect) 
– may be driven by 
increasing comorbidity 
burden in regions with 
lower levels of 
socioeconomic 
development 
 Finding: increased 
mortality in the Pardo 
and Black populations 
(ethnicity effect) – may 
be related to 
differences in 
susceptibility to 
COVID-19 and access 
to health care 























 Knowledge of 
community 
vulnerability to C19 




 This study assembled 
geospatial indicators to 
create 3 vulnerability 
indices to aid different 
tiers of the existing 
government in federal 
system of Nepal to 
prioritise and improve 
planning for disease 
intervention and 
especially so where 
C19 transmission 






















 Convalescent plasma 
could be an inexpensive 
and widely available 
treatment for COVID-
19  
 This randomised trial 
aimed to compare 
convalescent plasma 
with standard of care 
therapy in patients 
hospitalised with C19 in 
the Netherlands 
 The trial was halted 
prematurely though 
after enrolment of 86 
patients. No difference 
in mortality (p=0.95), 
hospital stay (p=0.68) or 
day-15 disease severity 
(p=0.58) was observed 
between plasma treated 
patients and patients on 
standard of care 
 Most C19 patients have 
high neutralising 
antibody titres when 
admitted to hospital. 
Screening for 
antibodies may help 
identify those that may 
















CGD | Policy 
Paper 
 Substantial evidence has 
emerged relating to the 
potential magnitude of the 
indirect health effects of the 
C19 pandemic 
 This paper provides an 
overview of the lessons 








outbreaks and economic 
crises in relation to indirect 
health effects 
 Also proposes a framework 
for adopting a whole of 
health approach to the C19 
response around 4 distinct by 
interrelated sets of impacts: 
economic, environmental, 
health systems, and 
social/behavioural 
 Authors apply this framework 
to discuss what is already 
known on the indirect health 
impacts of C19 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
04.07.2020 Offline” It’s time to convene nations to 
end this pandemic 
The Lancet | 
Comment 
Richard Horton 
03.07.2020 ‘I’m cautiously optimistic’: Imperial’s 
Robin Shattock on his coronavirus 
vaccine 
The Guardian | 
News 
Sarah Boseley 
02.07.2020 Will covid-19 be the catalyst for a “new 
deal” for the health and wellbeing of 
women, children and adolescents? 
BMJ | Blog Helen Clark 
02.07.2020 After COVID-19, a future for the 
world’s children? 





02.07.2020 EU guidance impedes humanitarian 
action to prevent COVID-19 in Syria 
The Lancet Global 




02.07.2020 COVID-19 in the Caribbean small 
island developing states: lessons 
learnt from extreme weather events  
The Lancet Global 
Health | Comment 






02.07.2020 Beyond lockdown – sustainable 
COVID control for low-income 
countries 






02.07.2020 Out of tragedy comes opportunity: how 
can global health multilateralism seize 
the moment? 
CGD | Blog Julia Kaufmann 





01.07.2020 The need for COVID-19 research in 





Madhu Gupta et 
al.  
01.07.2020 A framework for identifying the sources 
of indirect health effects of COVID-19 







30.06.2020 WHO & Partners enhance support to 
COVID-19 response in Rohingya 
camps in Cox’s Bazar 
WHO | News   
30.06.2020 Emerging COVID-19 success story: 
Vietnam’s commitment to containment 
Our World In Data | 
Guest post 
Todd Pollack et 
al. 
7 
29.06.2020 Healthcare technologies and COVID-
19: speed is not always a good thing 
CGD | Blog Kalipso 
Chalkidou et al.  
29.06.2020 “As One World we will be stronger” – 
We need words of hope, not war 
language 
ARISE | Blog Alfred Itunga 
Beate Ringwald 
26.06.2020 WHO, partners unveil ambitious plan 
to deliver 2 billion doses of Covid-19 
vaccine to high-risk populations 
STAT |News Helen Branswell 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 







 There is a need to understand 
different perspectives on vaccines 
and outbreaks to identify community 
perceptions surrounding vaccine 
use 
 This SSHAP Practical Approaches 
brief can be used by healthcare 
providers/NGOs, national and 
global-level policymakers, and 
industry actors to gain social 
science inputs in vaccine 
deployment efforts to provide 
practical solutions to re-occurring 
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  Sierra 
Leone 





US NIH  Our World 
in Data: C19 
Testing 




Our World in 
Data 






      
Global 5050 









  US  COVID-19 
Primer 





     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 




              
C19 Resource Hubs 









  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 







  IDA 






















g in low 
resource 
settings 














































Institute of Public 
Health 
    





Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     




 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
11 




    
Our World in 
Data 




  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  












      
WorldPop           
Flowminder           





    
  
GISAID           
  
12 
Online learning & events 











Online event 1h 30 JLN, WB, USAID, 






treatment of severe 
COVID-19  






mitigating the collateral 
effects of COVID-19 
Online event 1h 30 CGD 
13 July 




Lecture: Global Health 
Preparedness by Dr 
Muhammad Pate, 
Global Director for 
Health, Nutrition and 








UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 







Africa’s leadership role 
in COVID-19 vaccine 
development and 
access 












Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 




Modelling and Policy 
Online 
learning 













Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr 
Peter Lachman, Dr 
Teri Rynolds & Dr Ed 
Kelley 




5 hours Johns Hopkins 




Virtual Evidence Weeks 5 sessions 1h 30 International Initiative 











COVID-19 Open online 
brief with Dr David 
Nabarro 
Event 1h 4SD 
14 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





COVID-19: methods for 
detection, prevention, 
response and control 
Online 
learning 




19: Real-time training 

















































Edinburgh & Royal 
College of Physicians 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
